Philippe Clavel
Chief Executive Officer chez Curapath & Expansion of Drug Delivery Capabilities & Services
Profil
Philippe Clavel is currently the Chief Executive Officer at Curapath & Expansion of Drug Delivery Capabilities & Services.
He is also a Member-Supervisory Board at Réseau de Transport d'Electricité SA. Previously, he was the Chief Executive Officer at PCAS SA from 2021 to 2022, and Vice President at Seqens International SASU from 2020 to 2023.
He holds a doctorate degree from Université de Bordeaux and a graduate degree from École Nationale Supérieure de Chimie de Paris.
Postes actifs de Philippe Clavel
| Sociétés | Poste | Début |
|---|---|---|
Réseau de Transport d'Electricité SA
 Réseau de Transport d'Electricité SA Electric UtilitiesUtilities Réseau de Transport d'Electricité SA maintains and develops the French electricity transmission network. The company was founded in 2000 and is headquartered in Paris, France. | Director/Board Member | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
 Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Chief Executive Officer | 13/12/2023 |
Anciens postes connus de Philippe Clavel
| Sociétés | Poste | Fin |
|---|---|---|
Seqens International SASU
 Seqens International SASU Financial ConglomeratesFinance Seqens International SASU functions as an investment holding French company. The private company is based in Écully, France. | Private Equity Investor | 01/02/2023 |
Seqens International SASU
Seqens International SASU Financial ConglomeratesFinance Seqens International SASU functions as an investment holding French company. The private company is based in Écully, France. | Private Equity Investor | 01/02/2023 |
| PCAS | Chief Executive Officer | 28/11/2022 |
Formation de Philippe Clavel
| Université de Bordeaux | Doctorate Degree |
| École Nationale Supérieure de Chimie de Paris | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PCAS | Process Industries |
| Entreprise privées | 3 |
|---|---|
Réseau de Transport d'Electricité SA
Réseau de Transport d'Electricité SA Electric UtilitiesUtilities Réseau de Transport d'Electricité SA maintains and develops the French electricity transmission network. The company was founded in 2000 and is headquartered in Paris, France. | Utilities |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Health Technology |
Seqens International SASU
Seqens International SASU Financial ConglomeratesFinance Seqens International SASU functions as an investment holding French company. The private company is based in Écully, France. | Finance |
